Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Pramodini Medicare Ltd (PRAMODINI)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: PRAMODINI Hospital & Healthcare Services | Small Cap | Pramodini Medicare Share Price
BSE Share Price
Not Listed
Not Listed
Pramodini Medicare Ltd (PRAMODINI)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: PRAMODINI Hospital & Healthcare Services | Small Cap | Pramodini Medicare Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹280 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹7.9
TTM Sales
₹62.3 Cr.
Book Value per Share
₹26.5
P/E Ratio
16.14
Lower than its 5-year historical median
Industry PE
100.8
Price to Book (P/B)
4.79
In line with its 5-year historical median
Price to Sales (P/S)
4.50
Lower than its 5-year historical median
EV/EBITDA
9.12
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
39.08%
Outperforms industry median
Return on Capital Employed (ROCE)
41.85%
Outperforms industry median
Return on Assets (ROA)
23.76%
Operating Profit Margin
49.6%
Net Profit Margin
27.9%
Gross Profit Margin
49.3%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
8.54%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
47.35%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
56.01%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹36 Cr.
Equity
₹22.1 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
Quality
Somewhat GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Weak
Is Pramodini Medicare Ltd a good quality company?
Pramodini Medicare Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Pramodini Medicare Ltd performance compare with that of its Peers?
Revenue growth of Pramodini Medicare Ltd vs industry peers?
Pramodini Medicare Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 10.53%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Pramodini Medicare Ltd?
Promoters hold % of the Pramodini Medicare Ltd, with % of their stake pledged, indicating no pledge risk.
Stock return of Pramodini Medicare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Pramodini Medicare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|
| ROCE % ⓘ | 24.5% | 30.5% | 40.7% | - |
| Value Creation Index ⓘ | 0.8 | 1.2 | 1.9 | - |
Growth Parameters ⓘ |
||||
| Sales ⓘ | 30.6 | 35.2 | 38.2 | 38 |
| Sales YoY Gr. | - | 15.2% | 8.5% | - |
| Adj EPS ⓘ | 3.2 | 4.1 | 6.6 | 5 |
| YoY Gr. | - | 28.4% | 60.3% | - |
| BVPS (₹) ⓘ | 10.6 | 14.8 | 21.4 | 25.6 |
| Adj Net Profit ⓘ | 5.3 | 6.9 | 11 | 11 |
| Cash Flow from Ops. ⓘ | 7.2 | 10 | 22.2 | - |
| Debt/CF from Ops. ⓘ | 3 | 1.2 | 0.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | 8.5% | ||||
| Adj EPS ⓘ | NA | NA | NA | 60.3% | ||||
| BVPSⓘ | NA | NA | NA | 44.7% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|
| Return on Equity % ⓘ | 30.1 | 32.6 | 36.5 | 21.3 |
| Op. Profit Mgn % ⓘ | 47.4 | 43.5 | 54.5 | NAN |
| Net Profit Mgn % ⓘ | 17.2 | 19.5 | 28.8 | 28.8 |
| Debt to Equity ⓘ | 1.2 | 0.5 | 0.3 | - |
| Working Cap Days ⓘ | 0 | 253 | 254 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 92 | 93 | 0 |
Valuation of Pramodini Medicare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
No Data To Display
Promoter's Holding & Share Pledging
Financials
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|
| Sales | 31 | 35 | 38 | 62 |
| Operating Expenses ⓘ + | 16 | 20 | 17 | 31 |
| Operating Profit ⓘ | 15 | 16 | 21 | 31 |
| Operating Profit Margin (%) | 48.0% | 44.1% | 54.8% | 49.6% |
| Other Income ⓘ + | 0 | 1 | 0 | 1 |
| Interest ⓘ | 2 | 2 | 1 | 1 |
| Depreciation ⓘ | 5 | 4 | 4 | 7 |
| Profit Before Tax ⓘ | 7 | 10 | 16 | 23 |
| Tax ⓘ | 2 | 3 | 5 | 6 |
| Profit After Tax | 6 | 7 | 11 | 17 |
| PAT Margin (%) | 19.2% | 20.3% | 29.1% | 27.9% |
| Adjusted EPS (₹) | 2.6 | 4.2 | 6.6 | 10.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 17 | 25 | 36 | 53 | |||||||
| Debt + | 15 | 6 | 8 | 14 | |||||||
| Minority Interest | 0 | 0 | 0 | 0 | |||||||
| Trade Payables | 3 | 4 | 1 | 1 | |||||||
| Others Liabilities ⓘ | 12 | 12 | 10 | 24 | |||||||
| Total Liabilities ⓘ | 46 | 47 | 55 | 92 | |||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 20 | 16 | 22 | 44 | |||||||
| CWIP ⓘ | 0 | 0 | 0 | 0 | |||||||
| Investments ⓘ | 2 | 0 | 0 | 0 | |||||||
| Inventories | 0 | 0 | 0 | 1 | |||||||
| Trade Receivables | 14 | 18 | 11 | 17 | |||||||
| Cash Equivalents | 5 | 3 | 7 | 6 | |||||||
| Others Assets ⓘ | 4 | 10 | 14 | 23 | |||||||
| Total Assets ⓘ | 46 | 47 | 55 | 92 | |||||||
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 7 | 10 | 22 | 25 |
| Cash Flow From Investing Activity ⓘ + | -4 | -1 | -15 | -31 |
| Cash Flow From Financing Activity ⓘ + | -1 | -11 | -2 | 6 |
| Net Cash Flow ⓘ | 2 | -2 | 5 | 0 |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 35.53 | 34.59 | 36.81 | 39.08 | ||||||
| ROCE (%) | 25.54 | 31.38 | 40.8 | 41.85 | ||||||
| Asset Turnover Ratio | 0.67 | 0.76 | 0.75 | 0.85 | ||||||
| PAT to CFO Conversion(x) | 1.17 | 1.43 | 2 | 1.47 | ||||||
| Working Capital Days | ||||||||||
| Receivable Days | 172.30 | 167.70 | 139 | 83.70 | ||||||
| Inventory Days | 0.30 | 0.30 | 1.10 | 3.50 | ||||||
| Payable Days | 448.30 | 499.70 | 297 | 52.80 | ||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Pramodini Medicare Ltd FAQs
The current trading price of Pramodini Medicare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Pramodini Medicare stood at ₹280.4 Cr
The latest P/E ratio of Pramodini Medicare as of 31-Dec-1969 is 25.50.
The latest P/B ratio of Pramodini Medicare as of 31-Dec-1969 is 4.97.
The 52-week high of Pramodini Medicare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Pramodini Medicare is ₹38.24 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Pramodini Medicare Ltd is a average quality company.
The key valuation ratios of Pramodini Medicare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Pramodini Medicare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Pramodini Medicare Ltd
Pramodini Medicare was originally incorporated on September 12, 2000 under the name ‘Pramodini Medicare Private Limited’ in Andhra Pradesh. Subsequently, the status of the company was changed to public limited company and the name of the company was changed to ‘Pramodini Medicare Limited’ vide Special Resolution passed by the shareholders at the Extra Ordinary General Meeting of the company held on October 30, 2025.
The company is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. It also provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services include both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
Its business operates across four key models namely Public Private Partnership (with government hospitals and government teaching hospitals), Private Private Partnership (with private sector hospitals), Strategic Partnership with PSUs (Public Sector Undertakings) Government of India, and Private Centres (standalone centre). These models are based on hospital partnerships, where diagnostic centres are set up within the existing premises of hospitals, health centres and the company supports them by providing diagnostic testing service.
Business area of the company
The company is engaged in offering comprehensive solutions for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology to customers across states.
Services of the company
Radiology
- MRI
- CT Scan
- X-ray
- Ultrasound with colour doppler
- Mammography
- Dexa Scan
- Intervention Radiology
Clinical Laboratory
- Haematology
- Micro-Biology
- Immunology
- Pathology
- Bio-Chemistry
Nuclear Medicine
- PET-CT
- SPECT
- Nuclear therapy
History and milestones
- 2000: Incorporation of Pramodini Medicare Private Limited.
- 2015: Dr. Kuldeep Kumar Chalasani and Dr. Chalasani Kavitha were appointed as Directors on the Board of the company and installation of 128 slice CT scan at Vijayawada- Andhra Pradesh.
- 2017: Entered in Memorandum of Understanding (MOU) for 4 centres in Andhra Pradesh.
- 2021: Entered in Memorandum of Understanding (MOU) with Vista Imaging & Medical Centre Private Limited to incorporate Vista Pramodini Medicare Private Limited. Also entered in Memorandum of Understanding (MOU) for 3 centres in Uttar Pradesh.
- 2023: Entered in Memorandum of Understanding for 2 centres in Karnataka.
- 2024: Re-entered in Memorandum of Understanding for 3 centres in Uttar Pradesh and 1 centre in Kerala.
- 2025: Entered in Memorandum of Understanding for 1 centre in West Bengal, 1 centre in Karnataka and 1 centre in Harayana and NCR Delhi each.
- 2025: Conversion of the company from Private Limited to Public Limited Company in the name of ‘Pramodini Medicare Limited’.
You have 43 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
